Erowid.org: Erowid Reference 6882 : In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step : Staack RF, Theobald DS, Paul LD, Springer D, Kraemer T, Maurer HH

Erowid References Database

Staack RF, Theobald DS, Paul LD, Springer D, Kraemer T, Maurer HH. “In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step”. Xenobiotica. 2004 Feb;34(2):179-92. <a name="ref">Staack RF, Theobald DS, Paul LD, Springer D, Kraemer T, Maurer HH.</a> <a href="/references/6882">"In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step"</a> <i>Xenobiotica</i>. 2004 Feb;34(2):179-92.
Text Abstract (this page) Full Text - English (private) Show Articles by Staack RF Theobald DS Paul LD Springer D Kraemer T Maurer HH Article IDs Erowid RefID: 6882 PubMedID: 14985146 Collections Hofmann Collection MDMA Collection All References	Abstract 1. The in vivo metabolism of 1-(4-methoxyphenyl)piperazine (MeOPP), a novel designer drug, was studied in male Wistar rats. 2. MeOPP was mainly O-demethylated to 1-(4-hydroxyphenyl)piperazine (4-HO-PP) in addition to degradation of the piperazine moiety. 3. O-demethylation, the major metabolic step, was studied with cDNA-expressed human hepatic cytochrome P450 (CYP) enzymes in pooled human liver microsomes (pHLM) and in single donor human liver microsomes with CYP2D6 poor metabolizer genotype (PM HLM). 4. CYP2D6 catalysed O-demethylation with apparent Km and Vmax values of 48.34 +/- 14.48 microM and 5.44 +/- 0.47 pmol min(-1) pmol(-1) CYP, respectively. pHLM catalysed the monitored reaction with an apparent Km = 204.80 +/- 51.81 microM and Vmax = 127.50 +/- 13.25 pmol min(-1) mg(-1) protein. 5. The CYP2D6-specific chemical inhibitor quinidine (1 and 3 microM) significantly inhibited 4-HO-PP formation by 71.9 +/- 4.8% and by 98.5% +/- 0.5%, respectively, in incubation mixtures with pHLM and 200 microM MeOPP. 6. O-demethylation was significantly lower in PM HLM compared with pHLM (70.6% +/- 7.2%). 7. These data suggest that polymorphically expressed CYP2D6 is the enzyme mainly responsible for MeOPP O-demethylation.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]